We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$125M
1-Year Est. Return
91.82%
This Fund
S&P 500
This Quarter
Est. Return
+32.15%
1 Year Est. Return
+91.82%
3 Year Est. Return
+242.79%
5 Year Est. Return
+115.88%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$49.7M
(+45%)
Cap. Flow
+$17.9M
Cap. Flow
% of AUM
11.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twist Bioscience
TWST
|
+$11.9M |
| 2 |
GRAL
GRAIL Inc
GRAL
|
+$8.55M |
| 3 |
Quanterix
QTRX
|
+$7.05M |
| 4 |
TEM
Tempus AI
TEM
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$6.2M |
| 2 |
Guardant Health
GH
|
+$4.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AFA
KLCMU
SWA
PB
WOSD
MSK
CNTOF
SWM
Blue Water Life Science Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Blue Water Life Science Advisors held 9 positions worth $159M, up 45% from $110M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors deployed $17.9M of net new capital in Q4 2025, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Twist Bioscience: 383,000 shares worth $12.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the largest reduction was Adaptive Biotechnologies, an estimated $6.2M trimmed.
- Blue Water Life Science Advisors's largest Q4 2025 buy was Twist Bioscience: 383,000 shares worth $12.1M.
- Blue Water Life Science Advisors added most to Quanterix in Q4 2025, an estimated $7.05M increase.
- Blue Water Life Science Advisors's biggest Q4 2025 reduction was Adaptive Biotechnologies, cutting an estimated $6.2M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $159M portfolio in Q4 2025.
- Blue Water Life Science Advisors opened 2 new positions and closed 0 in Q4 2025.
- Blue Water Life Science Advisors's portfolio value rose 45% quarter-over-quarter to $159M.
Based on Blue Water Life Science Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.